Home LiteratureArticle Details
PMID: 19266020 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity.

PLoS genetics ·Vol. 5 ·No. 3 ·2009-03-00 ·Pages e1000399

Gidalevitz T, Krupinski T, Garcia S, Morimoto RI

Abstract

Genetic background exerts a strong modulatory effect on the toxicity of aggregation-prone proteins in conformational diseases. In addition to influencing the misfolding and aggregation behavior of the mutant proteins, polymorphisms in putative modifier genes may affect the molecular processes leading to the disease phenotype. Mutations in SOD1 in a subset of familial amyotrophic lateral sclerosis (ALS) cases confer dominant but clinically variable toxicity, thought to be mediated by misfolding and aggregation of mutant SOD1 protein. While the mechanism of toxicity remains unknown, both the nature of the SOD1 mutation and the genetic background in which it is expressed appear important. To address this, we established a Caenorhabditis elegans model to systematically examine the aggregation behavior and genetic interactions of mutant forms of SOD1. Expression of three structurally distinct SOD1 mutants in C. elegans muscle cells resulted in the appearance of heterogeneous populations of aggregates and was associated with only mild cellular dysfunction. However, introduction of destabilizing temperature-sensitive mutations into the genetic background strongly enhanced the toxicity of SOD1 mutants, resulting in exposure of several deleterious phenotypes at permissive conditions in a manner dependent on the specific SOD1 mutation. The nature of the observed phenotype was dependent on the temperature-sensitive mutation present, while its penetrance reflected the specific combination of temperature-sensitive and SOD1 mutations. Thus, the specific toxic phenotypes of conformational disease may not be simply due to misfolding/aggregation toxicity of the causative mutant proteins, but may be defined by their genetic interactions with cellular pathways harboring mildly destabilizing missense alleles.

MeSH Terms
Amyotrophic Lateral Sclerosis/enzymology,genetics Animals Bacterial Proteins/chemistry,genetics,metabolism,toxicity Caenorhabditis elegans/drug effects,genetics,metabolism Gene Expression Humans Luminescent Proteins/chemistry,genetics,metabolism,toxicity Muscle Cells/drug effects,metabolism Mutation Phenotype Polymorphism, Genetic Protein Folding Recombinant Fusion Proteins/chemistry,genetics,metabolism,toxicity Superoxide Dismutase/chemistry,genetics,metabolism,toxicity Superoxide Dismutase-1 Temperature
Chemicals
Bacterial Proteins Luminescent Proteins Recombinant Fusion Proteins SOD1 protein, human yellow fluorescent protein, Bacteria Superoxide Dismutase Superoxide Dismutase-1
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gidalevitz Tali
Department of Biochemistry, Molecular Biology, and Cell Biology, Rice Institute for Biomedical Research, Northwestern University, Evanston, Illinois, United States of America.
Krupinski Thomas
Garcia Susana
Morimoto Richard I
Conflict of Interest

The authors have declared that no competing interests exist.

References (50)
50 references, click to expand
  1. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia.
    Brain. 1997 Oct;120 ( Pt 10):1723-37 PMID: 9365366
  2. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS.
    J Neurol Sci. 2005 Sep 15;236(1-2):1-7 PMID: 16024047
  3. Mutant SOD1 detoxification mechanisms in intact single cells.
    Cell Death Differ. 2008 Feb;15(2):312-21 PMID: 17992192
  4. Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model.
    J Neurosci. 2006 Jul 19;26(29):7597-606 PMID: 16855087
  5. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones.
    Mol Biol Cell. 2004 Feb;15(2):657-64 PMID: 14668486
  6. Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase.
    J Biol Chem. 2002 May 3;277(18):15932-7 PMID: 11854285
  7. Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans post-synaptic muscle cells.
    Genes Dev. 2007 Nov 15;21(22):3006-16 PMID: 18006691
  8. Genetic mapping of a mouse modifier gene that can prevent ALS onset.
    Genomics. 2000 Dec 1;70(2):181-9 PMID: 11112346
  9. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila.
    PLoS Genet. 2007 Oct;3(10):1950-64 PMID: 17953484
  10. Mistranslation-induced protein misfolding as a dominant constraint on coding-sequence evolution.
    Cell. 2008 Jul 25;134(2):341-52 PMID: 18662548
  11. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions.
    Nat Genet. 1997 Jan;15(1):91-4 PMID: 8988176
  12. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans.
    Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10417-22 PMID: 12122205
  13. An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS.
    Nat Med. 2007 Jun;13(6):754-9 PMID: 17486090
  14. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels.
    Anal Biochem. 1971 Nov;44(1):276-87 PMID: 4943714
  15. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis.
    Science. 1996 Jan 26;271(5248):515-8 PMID: 8560268
  16. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.
    Brain. 2004 Jan;127(Pt 1):73-88 PMID: 14534160
  17. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans.
    Proc Natl Acad Sci U S A. 2000 May 23;97(11):5750-5 PMID: 10811890
  18. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.
    Science. 1994 Jun 17;264(5166):1772-5 PMID: 8209258
  19. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity.
    Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8292-6 PMID: 8058797
  20. Hsp90 as a capacitor for morphological evolution.
    Nature. 1998 Nov 26;396(6709):336-42 PMID: 9845070
  21. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis.
    J Neurosci. 2007 Nov 28;27(48):13173-80 PMID: 18045911
  22. Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis.
    Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1025-37 PMID: 16814528
  23. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide.
    Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5709-14 PMID: 8650157
  24. Genetic epidemiology of amyotrophic lateral sclerosis.
    Clin Genet. 2003 Feb;63(2):83-101 PMID: 12630951
  25. Adapting proteostasis for disease intervention.
    Science. 2008 Feb 15;319(5865):916-9 PMID: 18276881
  26. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging.
    PLoS Genet. 2008 Mar 21;4(3):e1000027 PMID: 18369446
  27. Progressive disruption of cellular protein folding in models of polyglutamine diseases.
    Science. 2006 Mar 10;311(5766):1471-4 PMID: 16469881
  28. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates.
    J Cell Biol. 2005 Oct 10;171(1):75-85 PMID: 16216923
  29. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.
    J Biol Chem. 2002 May 3;277(18):15923-31 PMID: 11854284
  30. Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans.
    Genes Dev. 2008 Dec 1;22(23):3236-41 PMID: 19056880
  31. The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis.
    Arch Neurol. 2006 Feb;63(2):262-7 PMID: 16476815
  32. Conformational disease.
    Nat Cell Biol. 2000 Nov;2(11):E207-9 PMID: 11056553
  33. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.
    Brain. 2006 Feb;129(Pt 2):451-64 PMID: 16330499
  34. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.
    Nature. 1993 Jul 22;364(6435):362 PMID: 8332197
  35. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies.
    Am J Hum Genet. 2007 Apr;80(4):727-39 PMID: 17357078
  36. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles.
    J Neurol Neurosurg Psychiatry. 1995 Sep;59(3):266-70 PMID: 7673954
  37. SMN protects cells against mutant SOD1 toxicity by increasing chaperone activity.
    Biochem Biophys Res Commun. 2007 Dec 28;364(4):850-5 PMID: 17964281
  38. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation.
    Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6403-8 PMID: 15084750
  39. Single charge change on the helical surface of the paramyosin rod dramatically disrupts thick filament assembly in Caenorhabditis elegans.
    J Mol Biol. 1991 Jun 5;219(3):429-41 PMID: 2051482
  40. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature.
    Hum Mol Genet. 2003 Nov 1;12(21):2753-64 PMID: 12966034
  41. Invertebrate models of Alzheimer's disease.
    Genes Brain Behav. 2005 Apr;4(3):147-56 PMID: 15810903
  42. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans.
    Nature. 2002 Oct 24;419(6909):808-14 PMID: 12397350
  43. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.
    Neuron. 1995 Jun;14(6):1105-16 PMID: 7605627
  44. Genetic studies of the Lac repressor. XV: 4000 single amino acid substitutions and analysis of the resulting phenotypes on the basis of the protein structure.
    J Mol Biol. 1996 Aug 30;261(4):509-23 PMID: 8794873
  45. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype.
    Hum Mutat. 2002 Dec;20(6):473 PMID: 12442272
  46. Genetic analysis of protein stability and function.
    Annu Rev Genet. 1989;23:289-310 PMID: 2694933
  47. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis.
    J Neurochem. 2004 Jun;89(6):1325-35 PMID: 15189335
  48. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.
    Neuron. 1997 Feb;18(2):327-38 PMID: 9052802
  49. ALS, SOD and peroxynitrite.
    Nature. 1993 Aug 12;364(6438):584 PMID: 8350919
  50. Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn superoxide dismutase gene.
    Neurology. 1995 Nov;45(11):2038-42 PMID: 7501156
Article Info
Journal
PLoS genetics
Abbr.
PLoS Genet
ISSN
1553-7404
Published
2009-03-00
Epub
2009-00-06
Pages
e1000399
Language
English
Region
United States
NLM ID
101239074
PMCID
PMC2642731
Subset
IM
Grants
NIGMS NIH HHS · R37 GM038109 · United States
NINDS NIH HHS · R21 NS056337 · United States
NIA NIH HHS · R01 AG026647 · United States
NIGMS NIH HHS · F32 GM075583 · United States
NIGMS NIH HHS · F32 GM75583 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com